When everyday counts: Neonatal treatment for pyridoxine-dependent epilepsy.

Nov 10, 2025·
Curtis Coughlin II
Curtis Coughlin II
· 0 min read
Emory University Hospital
Abstract
This lecture foucsed on current evidence for lysine-reduction therapies for patients with a genetic diagnosis of PDE-ALDH7A1 and the importance of a neonatal diagnosis and early treatment.
Date
Nov 10, 2025
Event
Metabolic Grand Rounds, Emory University
Location

In-person

Atlanta,

PDE-ALDH7A1
Curtis Coughlin II
Authors
Curtis Coughlin II
Associate Professor
Translational researcher focused on rare diseases and bioethics